Cargando…
Hepatic Impairment as a Risk Factor for Drug Safety: Suitability and Comparison of Four Liver Scores as Screening Tools
Hepatic impairment (HI) influences the pharmacokinetics and pharmacodynamics of drugs and represents an important risk factor for drug safety. A reliable screening tool for HI identification at hospital admission by pharmacists would be desirable but is currently lacking. Therefore, we tested four l...
Autores principales: | Golla, Kathrin, Benesic, Andreas, Mannell, Hanna, Dreischulte, Tobias, Grill, Eva, Strobach, Dorothea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649763/ https://www.ncbi.nlm.nih.gov/pubmed/37959279 http://dx.doi.org/10.3390/jcm12216814 |
Ejemplares similares
-
Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer
por: Haimerl, Lisa, et al.
Publicado: (2021) -
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study
por: Strobach, Dorothea, et al.
Publicado: (2023) -
Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission
por: Seiberth, Sarah, et al.
Publicado: (2020) -
Improving primary care prescribing safety using routine data for intervention and evaluation: four trials in 500+ practices
por: Guthrie, Bruce, et al.
Publicado: (2017) -
Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
por: Weber, Sabine, et al.
Publicado: (2020)